These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 20075437
1. Persistent alpha-Klotho (a-Kl) expression in the parathyroid glands of patients with secondary hyperparathyroidism. Ohkido I, Yokoyama K, Imura A, Utsunomiya Y, Hosoya T, Nabeshima Y. Nephrol Dial Transplant; 2010 Mar; 25(3):1007-8; author reply 1008-9. PubMed ID: 20075437 [No Abstract] [Full Text] [Related]
2. A correlation between decreased parathyroid α-Klotho and fibroblast growth factor receptor 1 expression with pathological category and parathyroid gland volume in dialysis patients. Yan J, Jingbo C, Wang D, Xie S, Yuan L, Zhong X, Hao L. Int Urol Nephrol; 2015 Apr; 47(4):701-6. PubMed ID: 25749987 [Abstract] [Full Text] [Related]
3. Involvement of alpha-klotho and fibroblast growth factor receptor in the development of secondary hyperparathyroidism. Kumata C, Mizobuchi M, Ogata H, Koiwa F, Nakazawa A, Kondo F, Kadokura Y, Kinugasa E, Akizawa T. Am J Nephrol; 2010 Apr; 31(3):230-8. PubMed ID: 20068287 [Abstract] [Full Text] [Related]
5. Analysis of α-klotho, fibroblast growth factor-, vitamin-D and calcium-sensing receptor in 70 patients with secondary hyperparathyroidism. Latus J, Lehmann R, Roesel M, Fritz P, Braun N, Ulmer C, Steurer W, Biegger D, Ott G, Dippon J, Alscher MD, Kimmel M. Kidney Blood Press Res; 2013 Dec; 37(1):84-94. PubMed ID: 23552627 [Abstract] [Full Text] [Related]
6. Klotho, FGF23, and FGF receptors in chronic kidney disease: a yin-yang situation? Drüeke TB. Kidney Int; 2010 Dec; 78(11):1057-60. PubMed ID: 21076444 [Abstract] [Full Text] [Related]
7. Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients. Krajisnik T, Olauson H, Mirza MA, Hellman P, Akerström G, Westin G, Larsson TE, Björklund P. Kidney Int; 2010 Nov; 78(10):1024-32. PubMed ID: 20686451 [Abstract] [Full Text] [Related]
8. Does the downregulation of the FGF23 signaling pathway in hyperplastic parathyroid glands contribute to refractory secondary hyperparathyroidism in CKD patients? Lafage-Proust MH. Kidney Int; 2010 Mar; 77(5):390-2. PubMed ID: 20150940 [Abstract] [Full Text] [Related]
9. Effects of FGF-23-mediated ERK/MAPK signaling pathway on parathyroid hormone secretion of parathyroid cells in rats with secondary hyperparathyroidism. Chen XJ, Chen X, Wu WJ, Zhou Q, Gong XH, Shi BM. J Cell Physiol; 2018 Sep; 233(9):7092-7102. PubMed ID: 29633272 [Abstract] [Full Text] [Related]
10. Differential expression and regulation of Klotho by paricalcitol in the kidney, parathyroid, and aorta of uremic rats. Ritter CS, Zhang S, Delmez J, Finch JL, Slatopolsky E. Kidney Int; 2015 Jun; 87(6):1141-52. PubMed ID: 25692955 [Abstract] [Full Text] [Related]
11. Persistent fibroblast growth factor 23 signalling in the parathyroid glands for secondary hyperparathyroidism in mice with chronic kidney disease. Kawakami K, Takeshita A, Furushima K, Miyajima M, Hatamura I, Kuro-O M, Furuta Y, Sakaguchi K. Sci Rep; 2017 Jan 17; 7():40534. PubMed ID: 28094278 [Abstract] [Full Text] [Related]
12. Parathyroidectomy in patients with chronic kidney disease: Impacts of different techniques on the biochemical and clinical evolution of secondary hyperparathyroidism. Albuquerque RFC, Carbonara CEM, Martin RCT, Dos Reis LM, do Nascimento CP, Arap SS, Moysés RMA, Jorgetti V, Montenegro FLM, de Oliveira RB. Surgery; 2018 Feb 17; 163(2):381-387. PubMed ID: 29146232 [Abstract] [Full Text] [Related]
13. Transcription factor MafB may play an important role in secondary hyperparathyroidism. Morito N, Yoh K, Usui T, Oishi H, Ojima M, Fujita A, Koshida R, Shawki HH, Hamada M, Muratani M, Yamagata K, Takahashi S. Kidney Int; 2018 Jan 17; 93(1):54-68. PubMed ID: 28964572 [Abstract] [Full Text] [Related]
14. A comparative study of the int-2 gene product in primary and secondary parathyroid lesions. Tseleni-Balafouta S, Thomopoulou G, Lazaris ACh, Koutselini H, Davaris PS. Eur J Endocrinol; 2002 Jan 17; 146(1):57-60. PubMed ID: 11751068 [Abstract] [Full Text] [Related]
15. Molecular mechanisms of secondary hyperparathyroidism. Silver J. Nephrol Dial Transplant; 2000 Jan 17; 15 Suppl 5():2-7. PubMed ID: 11073267 [No Abstract] [Full Text] [Related]
16. Atypical spindle cell lesions in secondary parathyroid hyperplasia. Masuda A, Nishikawa T, Yamamoto T, Aiba M, Kobayashi M. Histopathology; 2008 Feb 17; 52(3):402-4. PubMed ID: 18269591 [No Abstract] [Full Text] [Related]
17. Dual-specificity phosphatases are implicated in severe hyperplasia and lack of response to FGF23 of uremic parathyroid glands from rats. Román-García P, Carrillo-López N, Naves-Díaz M, Rodríguez I, Ortiz A, Cannata-Andía JB. Endocrinology; 2012 Apr 17; 153(4):1627-37. PubMed ID: 22334717 [Abstract] [Full Text] [Related]
18. Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients. Komaba H, Goto S, Fujii H, Hamada Y, Kobayashi A, Shibuya K, Tominaga Y, Otsuki N, Nibu K, Nakagawa K, Tsugawa N, Okano T, Kitazawa R, Fukagawa M, Kita T. Kidney Int; 2010 Feb 17; 77(3):232-8. PubMed ID: 19890272 [Abstract] [Full Text] [Related]
19. [Correlation of serum Bio-intact PTH (1-84) and parathyroid gland size in hemodialysed patients]. Inaba M, Imanishi Y, Ueda M, Cho H, Tahara H, Ishimura E, Nishizawa Y, Yamakawa T, Okuno S. Clin Calcium; 2005 Sep 17; 15 Suppl 1():64-6; discussion 66-7. PubMed ID: 16272632 [Abstract] [Full Text] [Related]
20. KLOTHO methylation is linked to uremic toxins and chronic kidney disease. Young GH, Wu VC. Kidney Int; 2012 Apr 17; 81(7):611-2. PubMed ID: 22419041 [Abstract] [Full Text] [Related] Page: [Next] [New Search]